ELIZABETH LANHAM: Open Payments
NPI 1760713390 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 25 payments from 8 companies in 2025. Trend: 2023 $276 · 2024 $646 · 2025 $794
Food & beverage: $794
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $372 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $200 |
| ABBVIE INC. | 3 | $71 |
| Vanda Pharmaceuticals Inc. | 2 | $42 |
| PFIZER INC. | 2 | $36 |
| Alkermes, Inc. | 1 | $30 |
| Phadia US Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: BREZTRI, CAPLYTA, AIRSUPRA, VRAYLAR, NURTEC ODT, QULIPTA, VIVITROL, ImmunoCAP.
Industry payments across KY — which companies pay providers there.
